Cite
Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy.
MLA
Stroeks, Sophie L. V. M., et al. “Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy.” Circulation. Genomic and Precision Medicine, vol. 16, no. 2, Apr. 2023, p. e003788. EBSCOhost, https://doi.org/10.1161/CIRCGEN.122.003788.
APA
Stroeks, S. L. V. M., Lunde, I. G., Hellebrekers, D. M. E. I., Claes, G. R. F., Wakimoto, H., Gorham, J., Krapels, I. P. C., Vanhoutte, E. K., van den Wijngaard, A., Henkens, M. T. H. M., Raafs, A. G., Sikking, M. A., Broers, J. L. V., Nabben, M., Jones, E. A. V., Heymans, S. R. B., Brunner, H. G., & Verdonschot, J. A. J. (2023). Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy. Circulation. Genomic and Precision Medicine, 16(2), e003788. https://doi.org/10.1161/CIRCGEN.122.003788
Chicago
Stroeks, Sophie L V M, Ida G Lunde, Debby M E I Hellebrekers, Godelieve R F Claes, Hiroko Wakimoto, Joshua Gorham, Ingrid P C Krapels, et al. 2023. “Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy.” Circulation. Genomic and Precision Medicine 16 (2): e003788. doi:10.1161/CIRCGEN.122.003788.